SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2007 Incidence and Mortality Web-based Report. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2010. http://www.cdc.gov/uscs.
  • 2
    Centers for Disease Control and Prevention (CDC). Vital signs: colorectal cancer screening, incidence, and mortality—United States, 2002–2010. MMWR Morb Mortal Wkly Rep. 2011;60:884889. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6026a4.htm?s_cid=mm6026a4_w. Accessed December 13, 2011.
  • 3
    Ward E, Halpern M, Schrag N, et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin. 2008;58:931.
  • 4
    Rim SH, Joseph DA, Steele CB, Thompson TD, Seeff LC. Colorectal cancer screening - United States, 2002, 2004, 2006, and 2008. MMWR Surveill Summ. 2011;60(Suppl):4246.
  • 5
    Shapiro JA, Seeff LC, Thompson TD, Nadel MR, Klabunde CN, Vernon SW. Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2008;17:16231630.
  • 6
    Agency for Healthcare Research and Quality. Enhancing the Use and Quality of Colorectal Cancer Screening. Rockville, MD: U.S. Department of Health and Human Services; 2010.
  • 7
    Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:16031607.
  • 8
    Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:19771981.
  • 9
    Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2008. National Cancer Institute. 2011.
  • 10
    Seeff LC, DeGroff A, Tangka F, et al. Development of a federally funded demonstration colorectal cancer screening program. Prev Chronic Dis. 2008;5:A64.
  • 11
    Centers for Disease Control and Prevention DoCPaC. National Breast and Cervical Cancer Early Detection Program (Breast and Cervical Program). 2011. http://www.cdc.gov/cancer/nbccedp. Accessed April 28, 2011.
  • 12
    U. S. Preventive Services Task Force. Screening for colorectal cancer: clinical summary of U.S. Preventive Services Task Force Recommendation. 2008. http://www.uspreventiveservicestaskforce.org/uspstf08/colocancer/colosum.htm. Accessed February 24, 2011.
  • 13
    Seeff LC, Royalty J, Helsel WE, et al. Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program. Cancer. 2013;119(suppl 15):2820-2833.
  • 14
    DeGroff A, Holden D, Goode Green S, Boehm J, Seeff LC, Tangka F. Start-up of the colorectal cancer screening demonstration program. Prev Chronic Dis. 2008;5:A38.
  • 15
    Stake RE. Multiple Case Study Analysis. New York: The Guilford Press; 2006.
  • 16
    Subramanian S, Tangka FKL, Hoover S, et al. Costs of planning and implementing the CDC's Colorectal Cancer Screening Demonstration Program. Cancer. 2013;119(suppl 15):2855-2862.
  • 17
    O'Malley AS, Beaton E, Yabroff KR, Abramson R, Mandelblatt J. Patient and provider barriers to colorectal cancer screening in the primary care safety-net. Prev Med. 2004;39:5663.
  • 18
    Beeker C, Kraft JM, Southwell BG, Jorgensen CM. Colorectal cancer screening in older men and women: Qualitative research findings and implications for intervention. J Community Health. 2000;25:263278.
  • 19
    Denberg TD, Melhado TV, Coombes JM, et al. Predictors of nonadherence to screening colonoscopy. J Gen Intern Med. 2005;20:989995.
  • 20
    Wender RC. Barriers to screening for colorectal cancer. Gastrointest Endosc Clin N Am. 2002;12:145170.
  • 21
    Glasgow RE, Marcus AC, Bull SS, Wilson KM. Disseminating effective cancer screening interventions. Cancer. 2004;101:12391250.
  • 22
    Boyatzis RE. Reliability is consistency of judgment. In: Transforming Qualitative Information: Thematic Analysis and Code Development. Thousand Oaks, CA: Sage; 1998:144159.
  • 23
    Lane DS, Cavanagh MF, Messina CR, Anderson JC. An academic medical center model for community colorectal cancer screening: the Centers for Disease Control and Prevention demonstration program experience. Acad Med. 2010;85:13541361.
  • 24
    Hendren S, Griggs JJ, Epstein RM, et al. Study protocol: a randomized controlled trial of patient navigation-activation to reduce cancer health disparities. BMC Cancer. 2010;10:551.
  • 25
    Percac-Lima S, Grant RW, Green A, et al. A patient-tailored navigator program for colorectal cancer screening in a community health center: a randomized controlled trial. J Gen Intern Med. 2008;23:237238.
  • 26
    MacQueen KM, McLellan E, Kay K, Milstein B. Codebook development for team-based qualitative analysis. Cult Anthropol Method. 1998;10:3136.
  • 27
    Miller MF, Wong JG. Reducing financial barriers enhances the return rate of stool Hemoccult packets. Am J Med Sci. 1993;306:98100.
  • 28
    Harris MA, Byles JE, Cockburn J, D'Este C. A general practice-based recruitment strategy for colorectal cancer screening. Aust N Z J Public Health. 2000;24:441443.
  • 29
    Freedman JD, Mitchell CK. A simple strategy to improve patient adherence to outpatient fecal occult blood testing. J Gen Intern Med. 1994;9:462464.
  • 30
    Fiscella K, Yosha A, Hendren SK, et al. Get screened: a pragmatic randomized controlled trial to increase mammography and colorectal cancer screening in a large, safety net practice. BMC Health Serv Res. 2010;10:280.
  • 31
    Baron RC, Rimer BK, Breslow RA, et al. Client-directed interventions to increase community demand for breast, cervical, and colorectal cancer screening a systematic review. Am J Prev Med. 2008;35(1 Suppl):S34S55.
  • 32
    Community Preventive Services Task Force. What is the Community Guide? 2011. http://www.thecommunityguide.org/index.html. Accessed October 2011.
  • 33
    Yin RK. Case Study Research: Designs and Methods. 4th ed. Thousand Oaks, CA: Sage; 2009.
  • 34
    Patton MQ. Qualitative Research and Evaluation Methods. 3rd ed. Thousand Oaks, CA: Sage; 2002.
  • 35
    Glaser B, Strauss AL. The discovery of grounded theory: Strategies for qualitative research. New York: Aldine de Gruyter.; 1967
  • 36
    ATLAS.ti [computer program]. Berlin, Germany: Atlas.ti Scientific Software Development GmbH; 2010.
  • 37
    Thomas DR. A General Inductive Approach for Analyzing Qualitative Evaluation Data. American Journal of Evaluation 2006;27:237246.
  • 38
    Rohan EA, Boehm J, DeGroff A, Glover-Kudon R, Preissle J. Implementing the CDC's Colorectal Cancer Screening Demonstration Program: wisdom from the field. Cancer. 2013;119(suppl 15):28702883.
  • 39
    Glover-Kudon R, DeGroff A, Rohan E, Preissle J, Boehm J. Developmental milestones across the programmatic life cycle: implementing the CDC's Colorectal Cancer Screening Demonstration Program. Cancer. 2013;119(suppl 15):29262939.
  • 40
    Centers for Disease Control and Prevention. Screen for Life: National Colorectal Cancer Action Campaign. Colorectal (Colon) Cancer. 2011. http://www.cdc.gov/cancer/colorectal/sfl/. Accessed May 2011.
  • 41
    Corney RH. Sex differences in general practice attendance and help seeking for minor illness. J Psychosom Res. 1990;34:525534.
  • 42
    Galdas PM, Cheater F, Marshall P. Men and health help-seeking behaviour: literature review. J Adv Nurs. 2005;49:616623.
  • 43
    Rafuse J. Men's attitudes about seeking health care may put them at risk, conference told. CMAJ. 1993;149:329330.
  • 44
    Lane DS, Messina CR, Cavanagh MF, Chen JJ. A provider intervention to improve colorectal cancer screening in county health centers. Med Care. 2008;46(9 Suppl 1):S109S116.
  • 45
    Klabunde CN, Cronin KA, Breen N, Waldron WR, Ambs AH, Nadel MR. Trends in colorectal cancer test use among vulnerable populations in the United States. Cancer Epidemiol Biomarkers Prev. 2011;20:16111621.
  • 46
    Shires DA, Divine G, Schum M, et al. Colorectal cancer screening use among insured primary care patients. Am J Manag Care. 2011;17:480488.
  • 47
    Klabunde CN, Schenck AP, Davis WW. Barriers to colorectal cancer screening among Medicare consumers. Am J Prev Med. 2006;30:313319.
  • 48
    Domati F, Travlos E, Cirilli C, et al. Attitude of the Italian general population towards prevention and screening of the most common tumors, with special emphasis on colorectal malignancies. Intern Emerg Med. 2009;4:213220.
  • 49
    McCaffery K, Wardle J, Waller J. Knowledge, attitudes, and behavioral intentions in relation to the early detection of colorectal cancer in the United Kingdom. Prev Med. 2003;36:525535.
  • 50
    Calazel-Benque A, Viguier J, Roussel C, et al. Organized colorectal cancer screening programmes: how to optimize efficiency in the general population. Eur J Cancer Prev. 2011;20(Suppl 1):S20S25.
  • 51
    Hay JL, Ford JS, Klein D, et al. Adherence to colorectal cancer screening in mammography-adherent older women. J Behav Med. 2003;26:553576.
  • 52
    McQueen A, Vernon SW, Meissner HI, Klabunde CN, Rakowski W. Are there gender differences in colorectal cancer test use prevalence and correlates? Cancer Epidemiol Biomarkers Prev. 2006;15:782791.
  • 53
    Shike M, Schattner M, Genao A, et al. Expanding colorectal cancer screening among minority women. Cancer. 2011;117:7076.
  • 54
    Mays GP, Scutchfield FD. Improving public health system performance through multiorganizational partnerships. Prev Chronic Dis. 2010;7:A116.
  • 55
    Yarnall KS, Pollak KI, Ostbye T, Krause KM, Michener JL. Primary care: is there enough time for prevention? Am J Public Health. 2003;93:635641.
  • 56
    Guerra CE, Schwartz JS, Armstrong K, Brown JS, Halbert CH, Shea JA. Barriers of and facilitators to physician recommendation of colorectal cancer screening. J Gen Intern Med. 2007;22:16811688.
  • 57
    Sabatino SA, Habarta N, Baron RC, et al. Interventions to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers systematic reviews of provider assessment and feedback and provider incentives. Am J Prev Med. 2008;35(1 Suppl):S67S74.
  • 58
    Bass SB, Gordon TF, Ruzek SB, et al. Perceptions of colorectal cancer screening in urban African American clinic patients: differences by gender and screening status. J Cancer Educ. 2011;26:121128.
  • 59
    Geiger TM, Miedema BW, Geana MV, Thaler K, Rangneka NJ, Cameron GT. Improving rates for screening colonoscopy: analysis of the health information national trends (HINTS I) data. Surg Endosc. 2008;22:527533.
  • 60
    DeBourcy AC, Lichtenberger S, Felton S, Butterfield KT, Ahnen DJ, Denberg TD. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med. 2007;23:169174.
  • 61
    Read the Law: The Affordable Care Act, Section by Section. HealthCare.gov http://www.healthcare.gov/law/full/, 2012.